Carter Robert Ross, CFO of Oncology Institute ($TOI), made one open market purchase of shares in the last year, totaling $9,434, with the latest on March 26, 2025. This ranks 4,365th among nearly 5,000 insiders, well below the average of $1.5 million per buyer. He also sold shares once for $879, most recently on January 2, 2026, ranking 11,553rd out of nearly 12,000 sellers versus an average of $8.6 million.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | A | Common Stock | 202914 | $0.00 | 436,725.0000 | 99,303,511 | 31.72% | 0.20% |
| March 27, 2026 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | J | Common Stock | 20320 | $3.07 | 416,405.0000 | 99,303,511 | 4.65% | 0.02% |
| March 17, 2026 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | J | Common Stock | 1314 | $3.59 | 233,811.0000 | 99,303,511 | 0.56% | 0.00% |
| Jan. 2, 2026 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | J | Common Stock | 244 | $3.67 | 235,125.0000 | 99,303,511 | 0.10% | 0.00% |
| Jan. 2, 2026 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | S | Common Stock | 247 | $3.56 | 235,122.0000 | 99,303,511 | 0.10% | 0.00% |
| Nov. 17, 2025 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | A | Common Stock | 195 | $0.00 | 235,369.0000 | 99,303,511 | 0.08% | 0.00% |
| May 21, 2025 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 1601 | $2.68 | 235,174.0000 | 90,661,800 | 0.68% | 0.00% |
| March 31, 2025 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | A | Class A Common Stock | 197368 | $0.00 | 236,775.0000 | 77,470,886 | 500.85% | 0.25% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | P | Common Warrant | 4528 | $0.13 | 4,528.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | P | Common Stock | 9056 | $1.04 | 39,407.0000 | 77,470,886 | 29.84% | 0.01% |
| March 19, 2025 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 1150 | $0.89 | 30,351.0000 | 77,470,886 | 3.65% | 0.00% |
| Jan. 6, 2025 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 258 | $0.34 | 31,501.0000 | 77,470,886 | 0.81% | 0.00% |
| Nov. 20, 2024 | Oncology Institute, Inc. | $TOI | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 235 | $0.14 | 31,759.0000 | 77,292,849 | 0.73% | 0.00% |